D.R. Barton, Jr.
My first job right out of college was with DuPont. A brand-new chemical engineer, I got my start working on the sprawling Savannah River Site.
I still to this day remember packing up my things and heading to the lush South Carolina landscape – bright-eyed and ready to begin my career.
It took me a few years, a lot of hard work – and after helping in the start up of a multimillion-dollar chemical plant and being called on to lead a much bigger start up of a uranium waste processing reactor – I was moved to “The First State” to work in the heart of DuPont – its headquarters.
I was brought on to lend that plant startup experience in the design and construction of a cutting-edge aerospace composites plant.
I look back at my entire time as a chemical engineer very fondly.
stock: Keryx Biopharmaceuticals, Inc.(KERX)
Advisors’ Opinion:
- [By Lisa Levin]
Thursday afternoon, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Keryx Biopharmaceuticals (NASDAQ: KERX) and Amicus Therapeutics, Inc. (NASDAQ: FOLD).
- [By Lisa Levin]
Keryx Biopharmaceuticals (NASDAQ: KERX) shares shot up 14 percent to $5.17 after the company announced positive top-line results from its pivotal Phase 3 study of ferric citrate for the treatment of iron deficiency anemia in adults with non-dialysis dependent chronic kidney disease.
- [By Lisa Levin]
Thursday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Keryx Biopharmaceuticals (NASDAQ: KERX) and Rockwell Medical Inc (NASDAQ: RMTI).
stock: The First of Long Island Corporation(FLIC)
Advisors’ Opinion:
- [By Dividends4Life]
The First of Long Island Corporation (FLIC) operates as a bank holding company for The First National Bank of Long Island that provides financial services. Sept. 19, the company increased its quarterly dividend 4% to $0.26 per share. The dividend is payable Oct. 11, 2013 to shareholders of record on October 3, 2013. The yield based on the new payout is 2.7%.
stock: Santander Consumer USA Holdings Inc.(SC)
Advisors’ Opinion:
- [By Wayne Duggan]
Height Financial Services analyst Edwin Groshans believes Credit Acceptance Corp, Santander Consumer USA Holdings Inc (NYSE: SC), Ally Financial Inc (NYSE: ALLY) and Capital One Financial Corp. (NYSE: COF).
- [By Jim Robertson]
On Friday, our Under the Radar Moversnewsletter suggested going long on small cap consumer financestock Santander Consumer USA Holdings (NYSE: SC):
stock: Jersey Elec.(a)
Advisors’ Opinion:
- [By Jake L’Ecuyer]
Agilent Technologies (NYSE: A) was also up, gaining 6.42 percent to $52.49 after the company announced its plans to separate into two public companies.
- [By Monica Gerson]
Agilent Technologies (NYSE: A) shares rose 5.45% to $52.01. The volume of Agilent Technologies shares traded was 736% higher than normal. Agilent announced its plans to separate into two public companies.
- [By Dave and Donald Moenning]
For those investors that like the comfort generally provided by a diversified portfolio, here’s an idea that will allow you to (a) maintain a diversified allocation in your portfolio and (b) stay out of trouble when the big, bad bears come to call on an asset class or two.
- [By Chris Lange]
Agilent Technologies Inc. (NYSE: A) is set to release its most recent quarterly results Monday as well. The consensus forecast calls for $0.62 in EPS on $1.17 billion in revenue. Shares ended the week at $68.79 apiece. The consensus price target is $72.15, and the 52-week range is $42.92 to $69.09.
- [By Sujan Lahiri]
(A)
The first stage is the removal (harvesting) of a sliver of dermal tissue, called a micro-organ (2-3mm diameter x 30-40mm length), from beneath the patient’s skin. This procedure is performed under a local anesthetic, is intended to be performed in a physician’s office and is minimally invasive, so as to encourage rapid healing with little or no scarring. Generally, more than one micro-organ will be harvested from the patient (typically 4-5).
stock: Veritiv Corporation(VRTV)
Advisors’ Opinion:
- [By Lisa Levin] Related CRMD Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher 12 Biggest Mid-Day Gainers For Tuesday CorMedix's (CRMD) CEO Khoso Baluch on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
Related BIOA Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates BioAmber (BIOA) Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
CorMedix Inc. (NYSE: CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update.
Bioamber Inc (NYSE: BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.
The Medicines Company (NASDAQ: MDCO) shares dipped 20.9 percent to $41.62.
Innocoll Holdings PLC (NASDAQ: INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold.
Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split.
Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period.
AmTrust Financial Services Inc (NASDAQ: AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016.
Qualstar Corporation (NASDAQ: QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 milli
